Moumita Sil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Moumita Sil has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Arunava Goswami
Biological Sciences Division, Indian Statistical Institute, Kolkata, India
13 shared publications - Arunava Goswami
Biological Science Division, Indian Statistical Institute, 203 B. T. Road, Kolkata 700108, West Bengal, India
6 shared publications - Debaleena Nawn
Computer Science & Engineering, School Of Engineering & Technology, Adamas University, Kolkata, 700 126, West Bengal, India
6 shared publications - Nabanita Mukherjee
Jangipur College, India
6 shared publications - Sk. Sarif Hassan
Department of Mathematics, Pingla Thana Mahavidyalaya, Maligram, Pingla, 721140, West Bengal, India
6 shared publications - Vladimir Nikolaevich Uversky
Department of Molecular Medicine and USF Health Byrd Alzheimer’s Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA
6 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by MDPI AG in Preprints.org
Mathematical Genomics of Mutation Hotspots in Human Hemoglobin Beta
Hemoglobin subunit beta (HBB) is essential for balanced hemoglobin assembly, and mutations in its short coding sequence cause severe hemoglobinopathies such as β-thalassemia. Pathogenic variants are not randomly distributed but cluster into mutation regions, forming hotspots that influence structural stability and disease progression. To characterize mutation regions, this study shifts focus from isolated point mutations to contiguous hotspot neighborhoods, defining 26 regions from 109 pathogenic mutation sites in the HBB human protein. Quantitative analyses of amino acid frequencies, polarity distributions, hydropathy n-grams, and intrinsic disorder profiles reveal that hotspots are compositionally robust yet unique: they preserve local stability through overlapping subsequences, while also exhibiting recurrence of signatures in distant non-overlapping fragments. Importantly, sequence homology analysis confirmed no relationship among hotspots, underscoring their uniqueness as ordered arrangements rather than simple sequence similarities. These findings highlight the power of quantitative hotspot analysis in uncovering hidden organizational principles of the HBB human sequence, with implications for predictive diagnostics and future comparative studies across globin families and clinical mutational spectra.
- 28 September 2026
- Published by MDPI AG in Preprints.org
Open AccessMathematical Genomics of Mutation Hotspots in Human Hemoglobin Beta
Hemoglobin subunit beta (HBB) is essential for balanced hemoglobin assembly, and mutations in its short coding sequence cause severe hemoglobinopathies such as β-thalassemia. Pathogenic variants are not randomly distributed but cluster into mutation regions, forming hotspots that influence structural stability and disease progression. To characterize mutation regions, this study shifts focus from isolated point mutations to contiguous hotspot neighborhoods, defining 26 regions from 109 pathogenic mutation sites in the HBB human protein. Quantitative analyses of amino acid frequencies, polarity distributions, hydropathy n-grams, and intrinsic disorder profiles reveal that hotspots are compositionally robust yet unique: they preserve local stability through overlapping subsequences, while also exhibiting recurrence of signatures in distant non-overlapping fragments. Importantly, sequence homology analysis confirmed no relationship among hotspots, underscoring their uniqueness as ordered arrangements rather than simple sequence similarities. These findings highlight the power of quantitative hotspot analysis in uncovering hidden organizational principles of the HBB human sequence, with implications for predictive diagnostics and future comparative studies across globin families and clinical mutational spectra.
- 24 August 2026
- Published by Springer Nature in Indian Journal of Microbiology
- p. 1-10
Nanomedicine from Ayurvedic Medicinal Plants
- 24 August 2026
- Published by Springer Nature in Indian Journal of Microbiology
- p. 1-10
Nanomedicine from Ayurvedic Medicinal Plants
- 4 April 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 817, 153717
Quantitative deciphering of mammalian histamine receptors through mathematical genomics
- 4 April 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 817, 153717
Quantitative deciphering of mammalian histamine receptors through mathematical genomics
- 16 February 2026
- Published by American Chemical Society (ACS) in ACS Agricultural Science & Technology
- Vol. 6 (4) , 561-574
Effects of Mesoporous Silica Nanoparticles on Seedling Growth of Vigna radiata and Glycolytic Metabolism in Bacillus coagulans
- 16 February 2026
- Published by American Chemical Society (ACS) in ACS Agricultural Science & Technology
- Vol. 6 (4) , 561-574
Effects of Mesoporous Silica Nanoparticles on Seedling Growth of Vigna radiata and Glycolytic Metabolism in Bacillus coagulans
- Open Access
- 13 February 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 9
Antimicrobials from nano sulfur: Innovations, applications, and future perspectives
- 13 February 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 9
Open AccessAntimicrobials from nano sulfur: Innovations, applications, and future perspectives
- Open Access
Quantitative Deciphering of Mammalian Histamine Receptors through Mathematical Genomics
Histamine receptors (HRH1–HRH4) are G-protein coupled receptors (GPCRs) that mediate essential physiological functions, including neurotransmission, gastric acid secretion, immune regulation, and presynaptic autoregulation. Despite their importance, systematic comparative analyses across mammalian histamine receptor sequences remain scarce. In this study, we performed a comprehensive evaluation of HRH1–HRH4 across multiple mammalian species, integrating sequence homology, invariant residue mapping, amino acid substitutions, compositional frequencies, Shannon entropy, polystring distributions, intrinsic disorder profiling, and phylogenetic clustering. HRH2 and HRH1 were highly conserved among primates, HRH3 showed strong cohesion within rodents, while HRH4 exhibited pronounced divergence consistent with immune-related specialization. Invariant residues localized to transmembrane helices and activation motifs (D107, W428/Y431, NPxxY), underscoring strict evolutionary constraints on ligand binding, receptor stability, and G-protein coupling. Substitutions were confined to non-essential lipid-facing and loop regions, predominantly conservative in nature, enabling diversification without disrupting the GPCR fold. Amino acid frequency and entropy analyses revealed hydrophobic dominance with subtype-specific enrichment of polar residues, while disorder profiling identified HRH1 as the most dynamic and HRH2 as the most structurally constrained. Polystring analysis highlighted conserved motifs (WWW, PP) alongside subtype- and species-specific repeats, reflecting evolutionary strategies balancing receptor stability with adaptive flexibility. Phylogenetic clustering confirmed subtype-specific cohesion, with HRH3 and HRH4 forming compact clades, HRH1 showing moderate dispersion, and HRH2 forming the most isolated cluster. Collectively, these findings demonstrate that mammalian histamine receptor evolution is governed by conserved biophysical cores and selective variability, offering insights into structural conservation, functional diversification, and translational relevance for drug design and model selection.
Open AccessQuantitative Deciphering of Mammalian Histamine Receptors through Mathematical Genomics
Histamine receptors (HRH1–HRH4) are G-protein coupled receptors (GPCRs) that mediate essential physiological functions, including neurotransmission, gastric acid secretion, immune regulation, and presynaptic autoregulation. Despite their importance, systematic comparative analyses across mammalian histamine receptor sequences remain scarce. In this study, we performed a comprehensive evaluation of HRH1–HRH4 across multiple mammalian species, integrating sequence homology, invariant residue mapping, amino acid substitutions, compositional frequencies, Shannon entropy, polystring distributions, intrinsic disorder profiling, and phylogenetic clustering. HRH2 and HRH1 were highly conserved among primates, HRH3 showed strong cohesion within rodents, while HRH4 exhibited pronounced divergence consistent with immune-related specialization. Invariant residues localized to transmembrane helices and activation motifs (D107, W428/Y431, NPxxY), underscoring strict evolutionary constraints on ligand binding, receptor stability, and G-protein coupling. Substitutions were confined to non-essential lipid-facing and loop regions, predominantly conservative in nature, enabling diversification without disrupting the GPCR fold. Amino acid frequency and entropy analyses revealed hydrophobic dominance with subtype-specific enrichment of polar residues, while disorder profiling identified HRH1 as the most dynamic and HRH2 as the most structurally constrained. Polystring analysis highlighted conserved motifs (WWW, PP) alongside subtype- and species-specific repeats, reflecting evolutionary strategies balancing receptor stability with adaptive flexibility. Phylogenetic clustering confirmed subtype-specific cohesion, with HRH3 and HRH4 forming compact clades, HRH1 showing moderate dispersion, and HRH2 forming the most isolated cluster. Collectively, these findings demonstrate that mammalian histamine receptor evolution is governed by conserved biophysical cores and selective variability, offering insights into structural conservation, functional diversification, and translational relevance for drug design and model selection.
- 12 July 2025
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 75 (3) , 1-34
Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers
The rising incidence of brain diseases parallels the global trend of an aging population, with Alzheimer’s disease (AD) being a leading neurodegenerative disorder characterized by memory loss, dementia, and cognitive decline. Despite extensive research, current treatments for AD remain largely symptomatic and have had limited success in halting disease progression, thereby shifting attention toward glial cells as promising therapeutic targets due to their emerging roles in AD pathogenesis. Astrocytes are involved in both beneficial and pathological processes in AD, such as cytokine secretion, Aβ removal, metabolic support, and tau pathology, with deficiency resulting in neuroinflammation and excitotoxicity. Microglia have dual functions in AD by phagocytosing amyloid plaques and limiting tau spread in initial phases but may develop a pro-inflammatory, neurodegenerative phenotype with progression of the disease. Oligodendrocytes and their precursors are involved in Aβ generation and myelin homeostasis, and their disturbance is responsible for white matter lesions and cognitive impairment, though their exact mechanisms are less clear. This review also examines emerging therapeutic strategies targeting glial cells, including modulating TREM2 pathways and novel drug candidates. These methods highlight the therapeutic value of the glial cells and provide valuable leads for furthering the treatment of AD by elucidating their changing roles in the course of the disease. Graphical Abstract
- 12 July 2025
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 75 (3) , 1-34
Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers
The rising incidence of brain diseases parallels the global trend of an aging population, with Alzheimer’s disease (AD) being a leading neurodegenerative disorder characterized by memory loss, dementia, and cognitive decline. Despite extensive research, current treatments for AD remain largely symptomatic and have had limited success in halting disease progression, thereby shifting attention toward glial cells as promising therapeutic targets due to their emerging roles in AD pathogenesis. Astrocytes are involved in both beneficial and pathological processes in AD, such as cytokine secretion, Aβ removal, metabolic support, and tau pathology, with deficiency resulting in neuroinflammation and excitotoxicity. Microglia have dual functions in AD by phagocytosing amyloid plaques and limiting tau spread in initial phases but may develop a pro-inflammatory, neurodegenerative phenotype with progression of the disease. Oligodendrocytes and their precursors are involved in Aβ generation and myelin homeostasis, and their disturbance is responsible for white matter lesions and cognitive impairment, though their exact mechanisms are less clear. This review also examines emerging therapeutic strategies targeting glial cells, including modulating TREM2 pathways and novel drug candidates. These methods highlight the therapeutic value of the glial cells and provide valuable leads for furthering the treatment of AD by elucidating their changing roles in the course of the disease. Graphical Abstract
- 25 June 2025
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 41 (7) , 1-17
Combating antimicrobial resistance: a closer look at disrupting Escherichia coli metabolism and motility with biogenic silver nanoparticles
Antimicrobial resistance (AMR) poses a dire global threat, with bacterial resistance predicted to cause 10 million deaths annually by 2050 if left unaddressed. Among the leading contributors, Escherichia coli ranks as a critical priority pathogen, driving the need for innovative strategies to combat resistance. This study addresses the urgent demand by exploring the antibacterial efficacy and mode of action of biogenic silver nanoparticles (AgNPs) synthesized using Emblica officinalis. AgNPs, characterized as spherical (average size: 46.5 nm) with high stability (zeta potential: -39.02 mV) and photoluminescent properties, exhibited potent antimicrobial activity, with minimum inhibitory concentrations ranging from 9.76 to 19.53 ppm. RNA-seq analysis revealed substantial metabolic and regulatory shifts in E. coli upon AgNP exposure, including upregulation of arginine biosynthesis, metabolism, and transport genes (e.g., argC, argB, argA, artJ), which supported ATP production via the Arginine Deiminase (ADI) pathway and enhanced stress resilience through polyamine synthesis. Upregulation of carA showed the interconnectedness of arginine and pyrimidine biosynthesis under energy-depleted conditions. Simultaneously, downregulation of motility-related genes (flhDC, fliC) disrupted flagellar biosynthesis, rendering E. coli non-motile and more vulnerable to oxidative stress. This was linked to reduced cAMP-CRP complex activity and arginine-sodium competition at flagellar motors. Structural analyses confirmed a face-centered cubic crystalline structure and functionalization with biomolecules, enhancing biocompatibility. Cytotoxicity assays on MDA-MB-231 cells demonstrated dose-dependent reductions in cell viability, with manageable safety profiles. These findings highlight biogenic AgNPs as eco-friendly, effective antimicrobial agents exploiting bacterial metabolic disruption and impaired motility to counter resistance, offering promising solutions to mitigate the AMR crisis. Graphical abstract
- 25 June 2025
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 41 (7) , 1-17
Combating antimicrobial resistance: a closer look at disrupting Escherichia coli metabolism and motility with biogenic silver nanoparticles
Antimicrobial resistance (AMR) poses a dire global threat, with bacterial resistance predicted to cause 10 million deaths annually by 2050 if left unaddressed. Among the leading contributors, Escherichia coli ranks as a critical priority pathogen, driving the need for innovative strategies to combat resistance. This study addresses the urgent demand by exploring the antibacterial efficacy and mode of action of biogenic silver nanoparticles (AgNPs) synthesized using Emblica officinalis. AgNPs, characterized as spherical (average size: 46.5 nm) with high stability (zeta potential: -39.02 mV) and photoluminescent properties, exhibited potent antimicrobial activity, with minimum inhibitory concentrations ranging from 9.76 to 19.53 ppm. RNA-seq analysis revealed substantial metabolic and regulatory shifts in E. coli upon AgNP exposure, including upregulation of arginine biosynthesis, metabolism, and transport genes (e.g., argC, argB, argA, artJ), which supported ATP production via the Arginine Deiminase (ADI) pathway and enhanced stress resilience through polyamine synthesis. Upregulation of carA showed the interconnectedness of arginine and pyrimidine biosynthesis under energy-depleted conditions. Simultaneously, downregulation of motility-related genes (flhDC, fliC) disrupted flagellar biosynthesis, rendering E. coli non-motile and more vulnerable to oxidative stress. This was linked to reduced cAMP-CRP complex activity and arginine-sodium competition at flagellar motors. Structural analyses confirmed a face-centered cubic crystalline structure and functionalization with biomolecules, enhancing biocompatibility. Cytotoxicity assays on MDA-MB-231 cells demonstrated dose-dependent reductions in cell viability, with manageable safety profiles. These findings highlight biogenic AgNPs as eco-friendly, effective antimicrobial agents exploiting bacterial metabolic disruption and impaired motility to counter resistance, offering promising solutions to mitigate the AMR crisis. Graphical abstract
- 20 June 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 777, 152240
Methuselah proteins in Drosophila: Structural and evolutionary insights from mathematical genomics
- 20 June 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 777, 152240
Methuselah proteins in Drosophila: Structural and evolutionary insights from mathematical genomics